Unicycive Therapeutics to Present at Upcoming Investor Conferences
LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will present at two upcoming virtual investment conferences. Event: Lytham Partners Spring 2025 Investor ConferenceType: Fireside Chat Date/Time: Thursday, May 29, 2025, at 12:30 p.m. ETEvent: Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference Get the latest news delivered to your inbox Sign up for The Manila Times newsletters By signing up with an email address,...